[Treatment of migraine in adults]
Boulanger MC
Record ID 32018014738
French
Original Title:
Traitement de la migraine chez l’adulte
Authors' objectives:
To improve the tools available to primary care practitioners to treat migraine, the
Association des neurologues du Québec commissioned the Institut national d’excellence
en santé et en services sociaux to develop a clinical tool for migraine treatment, which
was approved by the ministère de la Santé et des Services sociaux.
Authors' results and conclusions:
RESULTS (#1 INFORM HEALTHCARE PROFESSIONALS ABOUT AVAILABLE TREATMENT OPTIONS AND THEIR USE): To support clinicians in their choice of treatment, this clinical tool includes: 1) a general algorithm to
clarify the sequence of use of the various treatment options, 2) tables outlining the usage
conditions of the molecules that have been shown to be effective in treating migraine,
including certain factors to consider when choosing them. (#2 PROMOTING SHARED DECISION-MAKING): The clinical tool therefore
emphasizes the importance of the discussion when choosing treatment and also
includes, in an appendix, several points to be addressed in this discussion in order to
keep the person well informed and thus facilitate shared decision-making while promoting
their commitment to treatment. (#3 FACILITATING THE MAINTENANCE OF PRIMARY CARE FOLLOW-UPS): Access to more specialized care can sometimes be more difficult, resulting in delays of
treatment for people living with migraine. To optimize primary care management and limit
specialized consultations to situations that require them, the clinical tool first clarifies the
objectives of migraine treatment as well as the criteria for success and failure to be
considered in order to ensure an adequate transition between treatments and facilitate
primary care follow-up. CONCLUSION: Without replacing clinical judgment, this clinical tool should support practice, particularly
by providing information and benchmarks related to available pharmacological
treatments, their use, and the situations that require the advice of a medical specialist.
However, the potential benefits will depend on the diffusion of the clinical tool associated
with this report, as well as the adoption of clinical information and recommendations by
the concerned healthcare professionals.
Authors' recommendations:
Following the iterative process and triangulation of the information gathered, a series of
findings and recommendations were formulated. They are presented in this report and
are also included in the clinical tool. They are primarily intended for primary care health
professionals, including family physicians, nurse practitioners, and pharmacists.
Authors' methods:
To fulfill the mandate, a rapid review of best clinical practices for migraine treatment was
conducted based on publications listed in bibliographic databases and other sources of
information. The information was analyzed from the perspective of contextualizing
Quebec practice, based in particular on legislative, regulatory, and organizational factors
specific to Quebec and on the perspectives of the various stakeholders consulted. To
gather the perspectives of stakeholders, an advisory committee made up of clinicians
from different specialties and areas of expertise was created, and a consultation with
people living with migraine was conducted. Finally, external readers who are specialists
in the field of interest, as well as future users who did not participate in the work,
assessed the overall quality, acceptability, and applicability of the work.
Details
Project Status:
Completed
Year Published:
2025
URL for published report:
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/traitement-de-la-migraine.html
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
Canada
Province:
Quebec
MeSH Terms
- Migraine Disorders
- Adult
- Drug Therapy
- Disease Management
- Practice Guideline
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
L'Institut national d'excellence en sante et en services sociaux (INESSS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.